Table 3.
Model [Ref.] | Treatment | Treatment Duration | Dose and Administration | Change in Main Outcomes vs. Control (Relevant Concentrations) |
---|---|---|---|---|
Caco-2 cell monolayers [73] | Hesperetin vs. control Naringenin vs. control |
24 h | 100 µM |
Barrier function: TEER, occludin expression, claudin-4 expression, cytoskeletal association of occludin and claudin-1, and -3 FITC–dextran flux Barrier function: TEER, occludin expression, claudin-4 expression, cytoskeletal association of ZO-2, occludin and claudin-1, -3, and -4 FITC–dextran flux |
Caco-2 cell monolayers [74] | Naringenin vs. control | 48 h | 10, 30, 100 µM |
Barrier function: TEER (30, 100 µM)†, claudin-4 expression (30, 100 µM)†, cytoskeletal association of occludin, claudin-1, claudin-4 and ZO-2 (100 µM) FITC–dextran flux (30, 100 µM)† |
DSS-induced colitis in male BALB/c mice [76] | Naringenin vs. control diet | 9 days | 0.3% of the diet, oral administration |
Barrier function: Colonic permeability, claudin-1 expression Occludin, junctional adhesion molecule-A, claudin-3 expression Inflammation: DAI, colonic shortening, expression of cytokines (IFN-ϒ, IL-6, MIP-2, and IL-17A) |
DSS-induced colitis in male BALB/c mice [77] | Naringenin vs. control diet Hesperetin vs. control diet |
12 days | 0.3% of the diet, oral administration 0.3% of the diet, oral administration |
Barrier function: Colonic permeability Occludin expression Inflammation: Weight loss, colonic damage Colon length Barrier function: Colonic permeability, occludin expression Inflammation: Weight loss, colonic damage Colon length |
DSS-induced colitis in male BALB/c mice [78] | Hesperidin vs. control | 7 days | 10, 40, 80 mg/kg, oral administration |
Inflammation: DAI, MPO, MDA, IL-6, colonic wet weight (10, 40, 80 mg/kg)† Mucosal cell damage (80 mg/kg) IL-4 (10, 40, 80 mg/kg) |
TNBS-induced colitis in female Wistar rats [79] | Hesperidin vs. control | Twice (48 h pre- + 48 h post-colitis induction) | 2.5, 5, 10, 25, 50 mg/kg, oral administration |
Inflammation: Colonic damage, colonic weight, colonic MPO (10, 25 mg/kg) Glutathione levels (10, 25 mg/kg), colonic fluid absorption (10–50 mg/kg) MDA, LTB4 (2.5–50 mg/kg) |
TNBS- induced colitis in male Wistar rats [80] | Orange juice vs. control Grapefruit juice vs. control Combination vs. control |
15 days | 2 mL/kg, 5 mL/kg, 8 mL/kg, oral administration 0.1 mL/kg, 0.3 mL/kg, 0.5 mL/kg, oral administration 2 mL/kg OJ + 0.1 mL/kg GJ (low dose), 5 mL/kg OJ + 0.3 mL/kg GJ (high dose), oral administration |
Inflammation: Colonic damage (2, 5, 8 mL/kg), MPO, CRP (5, 8 mL/kg), ALP (8 mg/kg) GSH (8 mL/kg) Inflammation: Colonic damage (0.1, 0.3, 0.5 mL/kg) MPO, CRP (0.3, 0.5 mL/kg), ALP (0.3, 0.5 mL/kg) GSH (0.3 mL/kg) Inflammation: Colonic damage, MPO, CRP, ALP (low dose, high dose) GSH (high dose) |
DNBS- induced colitis in Male CD1 mice [81] | Bergamot juice extract vs. control | 4 days | 5, 10, 20 mg/kg, oral administration |
Inflammation: Colonic damage, weight loss, MPO, TNF-α, IL-1β, ICAM-1, p-selectin, nitrotyrosine, PAR, nuclear NF-kB translocation, p-JNK activation (20 mg/kg) Colon length (20 mg/kg) |
LPS-challenged broiler chickens [82] | Hesperidin vs. control diet | 42 days | 20 mg/kg diet, oral administration |
Inflammation: Phagocytic index, villus length, villus width, villus length/crypt depth Crypt depth Body weight gain, feed intake feed conversion ratio |
Human subjects with features of metabolic syndrome [68] | Citrus extract (>80% hesperidin-2S and <4% of naringin) vs. placebo | 12 weeks | 500 mg, oral administration | Inflammation: Calprotectin |
TEER, transepithelial electrical resistance. FITC, fluorescein isothiocyanate. ZO-2, zonula occludens 2. DSS, dextran sulfate sodium. DAI, disease activity index. IFN-ϒ, interferon-ϒ. IL, interleukin. MIP-2, macrophage inflammatory protein-2. MPO, myeloperoxidase. MDA, malondialdehyde. TNBS, trinitrobenzene sulfonic acid. LBT4, leukotriene B4. OJ, orange juice. GJ, grapefruit juice. CRP, C-reactive protein. ALP, alkaline phosphatase. GSH, glutathione. DNBS, dinitrobenzene sulfonic acid. TNF-α, tumor necrosis factor-α. ICAM-1, intercellular adhesion molecule-1. PAR, poly ADP-ribose. NF-kB, nuclear factor-kB. , increase. , decrease. , no significant change. †, dose-dependent effect.